Statistics

Total Visits

Views
A multicenter randomized study comparing temozolomide (TMZ) versus TMZ-plus-bevacizumab (BEV) before standard treatment in unresectable glioblastoma (GBM) patients (p): The GENOM 009 study by the GEINO group38

Select a period of time:

Number of views in the range

Views
A multicenter randomized study comparing temozolomide (TMZ) versus TMZ-plus-bevacizumab (BEV) before standard treatment in unresectable glioblastoma (GBM) patients (p): The GENOM 009 study by the GEINO group17

Views

Views
December 20241
January 20252
February 20255
March 20255
April 20253
May 20251
June 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States9
Singapore5
Argentina1
Germany1
Spain1
 

Top cities views

Views
Council Bluffs1
Laferrere1
Nuremberg1